Your browser doesn't support javascript.
loading
Identification of adipocyte plasma membrane-associated protein as a novel modulator of human cytomegalovirus infection.
Ye, Xiaohua; Gui, Xun; Freed, Daniel C; Ku, Zhiqiang; Li, Leike; Chen, Yuanzhi; Xiong, Wei; Fan, Xuejun; Su, Hang; He, Xi; Rustandi, Richard R; Loughney, John W; Ma, Ningning; Espeseth, Amy S; Liu, Jian; Zhu, Hua; Wang, Dai; Zhang, Ningyan; Fu, Tong-Ming; An, Zhiqiang.
Affiliation
  • Ye X; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Texas, United States of America.
  • Gui X; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Texas, United States of America.
  • Freed DC; MRL, Merck & Co., Inc., Kenilworth, NJ, United States of America.
  • Ku Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Texas, United States of America.
  • Li L; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Texas, United States of America.
  • Chen Y; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Texas, United States of America.
  • Xiong W; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Texas, United States of America.
  • Fan X; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Texas, United States of America.
  • Su H; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Texas, United States of America.
  • He X; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, China.
  • Rustandi RR; MRL, Merck & Co., Inc., Kenilworth, NJ, United States of America.
  • Loughney JW; MRL, Merck & Co., Inc., Kenilworth, NJ, United States of America.
  • Ma N; MRL, Merck & Co., Inc., Kenilworth, NJ, United States of America.
  • Espeseth AS; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, China.
  • Liu J; MRL, Merck & Co., Inc., Kenilworth, NJ, United States of America.
  • Zhu H; Rutgers Medical School of New Jersey, Newark, NJ, United States of America.
  • Wang D; Rutgers Medical School of New Jersey, Newark, NJ, United States of America.
  • Zhang N; MRL, Merck & Co., Inc., Kenilworth, NJ, United States of America.
  • Fu TM; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Texas, United States of America.
  • An Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Texas, United States of America.
PLoS Pathog ; 15(7): e1007914, 2019 07.
Article in En | MEDLINE | ID: mdl-31356650
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Membrane Glycoproteins / Cytomegalovirus Infections / Cytomegalovirus Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: PLoS Pathog Year: 2019 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Membrane Glycoproteins / Cytomegalovirus Infections / Cytomegalovirus Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: PLoS Pathog Year: 2019 Document type: Article Affiliation country: United States Country of publication: United States